Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma
Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The management of advanced-stage renal cell carcinoma (RCC) has been transformed by the development of immune-checkpoint inhibitors (ICIs). Nonetheless, most patients do not derive durable clinical benefit from these agents. Importantly, unlike other immunotherapy-responsive solid tumours, most RCCs have only a moderate mutational burden, and parad...
Alternative Titles
Full title
Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2477518041
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2477518041
Other Identifiers
ISSN
1759-4774,1759-4782
E-ISSN
1759-4782
DOI
10.1038/s41571-020-00455-z
